Movano (MOVE) said Tuesday it has begun a clinical trial with its new cuffless blood pressure wrist wearable.
The company said in the study, the device will be used to monitor pulse pressure waveforms compared with a hospital grade blood pressure device and will also collect data on pulse rate, blood oxygen saturation and other vital signs.
The trial is expected to include at least 70 participants and be finished in the second week of February, Movano said.
The company said the study follows three clinical trials where it used its non-invasive devices to collect pulse pressure waveform data from more than 60 participants.
Price: 5.43, Change: +0.03, Percent Change: +0.56
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.